RYBREVANT

Google image searchProduct monograph

Active ingredient

amivantamab, 350 MG/7 ML

DIN: 02526182

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: JANSSEN INC

Date: 26-APR-2022

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FX — Other monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
• L01FX18 — AMIVANTAMAB (ATC/DDD)

External Links for Rybrevant

Search on Google

• Rybrevant side effects
• Rybrevant dosage
• amivantamab side effects
• amivantamab dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find rybrevant photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.